학술논문
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology November 2021 9(11):755-766
Subject
Language
ISSN
2213-8587